Primary |
Cataract Operation |
18.2% |
Dysmenorrhoea |
18.2% |
Pain |
15.2% |
Eye Irrigation |
6.1% |
Eye Operation |
6.1% |
Preoperative Care |
6.1% |
Abdominal Pain |
3.0% |
Anaesthesia |
3.0% |
Back Pain |
3.0% |
Bronchitis |
3.0% |
Headache |
3.0% |
Intervertebral Disc Protrusion |
3.0% |
Juvenile Arthritis |
3.0% |
Product Used For Unknown Indication |
3.0% |
Spinal Osteoarthritis |
3.0% |
Swelling |
3.0% |
|
Renal Failure Acute |
16.0% |
Acute Febrile Neutrophilic Dermatosis |
8.0% |
Diarrhoea |
8.0% |
Agranulocytosis |
4.0% |
Body Temperature Decreased |
4.0% |
Drug Eruption |
4.0% |
Drug Ineffective |
4.0% |
Loss Of Consciousness |
4.0% |
Oedema |
4.0% |
Pancreatitis |
4.0% |
Product Quality Issue |
4.0% |
Renal Tubular Necrosis |
4.0% |
Respiratory Failure |
4.0% |
Toxic Anterior Segment Syndrome |
4.0% |
Toxicity To Various Agents |
4.0% |
Tubulointerstitial Nephritis And Uveitis Syndrome |
4.0% |
Urticaria |
4.0% |
Vomiting |
4.0% |
Wheezing |
4.0% |
White Blood Cell Count Increased |
4.0% |
|
Secondary |
Product Used For Unknown Indication |
34.4% |
Headache |
12.0% |
Ill-defined Disorder |
9.4% |
Bone Disorder |
6.0% |
Respiratory Disorder |
6.0% |
Therapeutic Embolisation |
3.8% |
Postoperative Care |
3.3% |
Drug Use For Unknown Indication |
2.8% |
Constipation |
2.7% |
Infection |
2.7% |
Pyrexia |
2.6% |
Parkinson's Disease |
2.1% |
Kawasaki's Disease |
2.0% |
General Anaesthesia |
1.8% |
Prophylaxis |
1.7% |
Analgesic Therapy |
1.7% |
Preoperative Care |
1.7% |
Arthritis |
1.4% |
Bone Pain |
1.3% |
Anaesthesia Procedure |
0.9% |
|
Drug Rash With Eosinophilia And Systemic Symptoms |
23.5% |
Abnormal Dreams |
15.1% |
Inflammation |
11.8% |
Toxic Anterior Segment Syndrome |
5.9% |
Scintillating Scotoma |
5.0% |
Cerebral Haematoma |
4.2% |
Atrial Fibrillation |
3.4% |
Drug Hypersensitivity |
3.4% |
Pupils Unequal |
3.4% |
Toxic Epidermal Necrolysis |
3.4% |
Colitis Collagenous |
2.5% |
Lymphocyte Stimulation Test Positive |
2.5% |
Rash |
2.5% |
Renal Failure Acute |
2.5% |
Rhabdomyolysis |
2.5% |
Abnormal Sensation In Eye |
1.7% |
Blood Creatinine Increased |
1.7% |
Cerebrovascular Accident |
1.7% |
Coronary Artery Disease |
1.7% |
Dermatitis Bullous |
1.7% |
|
Concomitant |
Product Used For Unknown Indication |
35.8% |
Prophylaxis |
11.8% |
Rheumatoid Arthritis |
11.0% |
Drug Use For Unknown Indication |
7.6% |
Pain |
5.9% |
Cancer Pain |
2.8% |
Constipation |
2.8% |
Osteoporosis |
2.5% |
Infection Prophylaxis |
2.2% |
Premedication |
2.1% |
Back Pain |
1.9% |
General Anaesthesia |
1.9% |
Multiple Myeloma |
1.9% |
Analgesic Therapy |
1.8% |
Insomnia |
1.6% |
Hypertension |
1.4% |
Deafness |
1.3% |
Pyrexia |
1.3% |
Tonsillitis |
1.3% |
Adverse Event |
1.2% |
|
Renal Failure Acute |
13.0% |
Pyrexia |
7.3% |
White Blood Cell Count Decreased |
7.3% |
Drug Prescribing Error |
6.8% |
Vomiting |
6.8% |
Sepsis |
5.2% |
Pulmonary Embolism |
4.7% |
Rash |
4.7% |
Tuberculosis |
4.2% |
Urinary Tract Infection |
4.2% |
Convulsion |
3.6% |
Delayed Recovery From Anaesthesia |
3.6% |
Gastric Cancer |
3.6% |
Platelet Count Decreased |
3.6% |
Pneumonia |
3.6% |
Septic Shock |
3.6% |
Staphylococcal Infection |
3.6% |
Stomatitis |
3.6% |
Tachycardia |
3.6% |
Hypertension |
3.1% |
|
Interacting |
Ankylosing Spondylitis |
50.0% |
Product Used For Unknown Indication |
50.0% |
|
|